UniProt ID | FGR_HUMAN | |
---|---|---|
UniProt AC | P09769 | |
Protein Name | Tyrosine-protein kinase Fgr | |
Gene Name | FGR | |
Organism | Homo sapiens (Human). | |
Sequence Length | 529 | |
Subcellular Localization |
Cell membrane Lipid-anchor Cytoplasmic side . Cell membrane Peripheral membrane protein Cytoplasmic side. Cell projection, ruffle membrane. Cytoplasm, cytosol. Cytoplasm, cytoskeleton. Mitochondrion inner membrane. Mitochondrion intermembrane space. |
|
Protein Description | Non-receptor tyrosine-protein kinase that transmits signals from cell surface receptors devoid of kinase activity and contributes to the regulation of immune responses, including neutrophil, monocyte, macrophage and mast cell functions, cytoskeleton remodeling in response to extracellular stimuli, phagocytosis, cell adhesion and migration. Promotes mast cell degranulation, release of inflammatory cytokines and IgE-mediated anaphylaxis. Acts downstream of receptors that bind the Fc region of immunoglobulins, such as MS4A2/FCER1B, FCGR2A and/or FCGR2B. Acts downstream of ITGB1 and ITGB2, and regulates actin cytoskeleton reorganization, cell spreading and adhesion. Depending on the context, activates or inhibits cellular responses. Functions as negative regulator of ITGB2 signaling, phagocytosis and SYK activity in monocytes. Required for normal ITGB1 and ITGB2 signaling, normal cell spreading and adhesion in neutrophils and macrophages. Functions as positive regulator of cell migration and regulates cytoskeleton reorganization via RAC1 activation. Phosphorylates SYK (in vitro) and promotes SYK-dependent activation of AKT1 and MAP kinase signaling. Phosphorylates PLD2 in antigen-stimulated mast cells, leading to PLD2 activation and the production of the signaling molecules lysophosphatidic acid and diacylglycerol. Promotes activation of PIK3R1. Phosphorylates FASLG, and thereby regulates its ubiquitination and subsequent internalization. Phosphorylates ABL1. Promotes phosphorylation of CBL, CTTN, PIK3R1, PTK2/FAK1, PTK2B/PYK2 and VAV2. Phosphorylates HCLS1 that has already been phosphorylated by SYK, but not unphosphorylated HCLS1.. | |
Protein Sequence | MGCVFCKKLEPVATAKEDAGLEGDFRSYGAADHYGPDPTKARPASSFAHIPNYSNFSSQAINPGFLDSGTIRGVSGIGVTLFIALYDYEARTEDDLTFTKGEKFHILNNTEGDWWEARSLSSGKTGCIPSNYVAPVDSIQAEEWYFGKIGRKDAERQLLSPGNPQGAFLIRESETTKGAYSLSIRDWDQTRGDHVKHYKIRKLDMGGYYITTRVQFNSVQELVQHYMEVNDGLCNLLIAPCTIMKPQTLGLAKDAWEISRSSITLERRLGTGCFGDVWLGTWNGSTKVAVKTLKPGTMSPKAFLEEAQVMKLLRHDKLVQLYAVVSEEPIYIVTEFMCHGSLLDFLKNPEGQDLRLPQLVDMAAQVAEGMAYMERMNYIHRDLRAANILVGERLACKIADFGLARLIKDDEYNPCQGSKFPIKWTAPEAALFGRFTIKSDVWSFGILLTELITKGRIPYPGMNKREVLEQVEQGYHMPCPPGCPASLYEAMEQTWRLDPEERPTFEYLQSFLEDYFTSAEPQYQPGDQT | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Myristoylation | ------MGCVFCKKL ------CCCEECCCC | 19.12 | - | |
3 | S-palmitoylation | -----MGCVFCKKLE -----CCCEECCCCE | 1.73 | - | |
6 | S-palmitoylation | --MGCVFCKKLEPVA --CCCEECCCCEECE | 1.57 | - | |
16 | Ubiquitination | LEPVATAKEDAGLEG CEECEECCCCCCCCC | 52.34 | - | |
27 | Phosphorylation | GLEGDFRSYGAADHY CCCCCHHHCCCCCCC | 28.10 | 26356563 | |
28 | Phosphorylation | LEGDFRSYGAADHYG CCCCHHHCCCCCCCC | 13.41 | 26356563 | |
34 | Phosphorylation | SYGAADHYGPDPTKA HCCCCCCCCCCCCCC | 30.79 | 27155012 | |
39 | Phosphorylation | DHYGPDPTKARPASS CCCCCCCCCCCCCHH | 44.72 | 26356563 | |
45 | Phosphorylation | PTKARPASSFAHIPN CCCCCCCHHHCCCCC | 28.77 | 28348404 | |
46 | Phosphorylation | TKARPASSFAHIPNY CCCCCCHHHCCCCCC | 28.67 | 28857561 | |
53 | Phosphorylation | SFAHIPNYSNFSSQA HHCCCCCCCCCCCCC | 10.31 | 28348404 | |
54 | Phosphorylation | FAHIPNYSNFSSQAI HCCCCCCCCCCCCCC | 37.73 | 28857561 | |
57 | Phosphorylation | IPNYSNFSSQAINPG CCCCCCCCCCCCCCC | 26.28 | 28348404 | |
58 | Phosphorylation | PNYSNFSSQAINPGF CCCCCCCCCCCCCCC | 21.35 | 28348404 | |
86 | Phosphorylation | VTLFIALYDYEARTE EEEEEEEEECCCCCC | 13.88 | 25884760 | |
97 | Phosphorylation | ARTEDDLTFTKGEKF CCCCCCCEECCCCEE | 35.93 | 29759185 | |
99 | Phosphorylation | TEDDLTFTKGEKFHI CCCCCEECCCCEEEE | 32.67 | 29759185 | |
173 | Phosphorylation | GAFLIRESETTKGAY CCEEEEECCCCCCEE | 30.32 | 28152594 | |
175 | Phosphorylation | FLIRESETTKGAYSL EEEEECCCCCCEEEE | 42.99 | 28152594 | |
176 | Phosphorylation | LIRESETTKGAYSLS EEEECCCCCCEEEEE | 24.35 | 28152594 | |
177 | Ubiquitination | IRESETTKGAYSLSI EEECCCCCCEEEEEE | 49.30 | 21890473 | |
180 | Phosphorylation | SETTKGAYSLSIRDW CCCCCCEEEEEEEEC | 20.86 | 30266825 | |
181 | Phosphorylation | ETTKGAYSLSIRDWD CCCCCEEEEEEEECC | 18.33 | 30266825 | |
183 | Phosphorylation | TKGAYSLSIRDWDQT CCCEEEEEEEECCCC | 15.05 | 28152594 | |
208 | Phosphorylation | RKLDMGGYYITTRVQ EEECCCCEEEEEEEE | 5.98 | 27155012 | |
209 | Phosphorylation | KLDMGGYYITTRVQF EECCCCEEEEEEEEC | 8.61 | 30108239 | |
211 | Phosphorylation | DMGGYYITTRVQFNS CCCCEEEEEEEECCC | 7.76 | 26356563 | |
212 | Phosphorylation | MGGYYITTRVQFNSV CCCEEEEEEEECCCH | 21.20 | 26356563 | |
218 | Phosphorylation | TTRVQFNSVQELVQH EEEEECCCHHHHHHH | 26.85 | - | |
259 | Phosphorylation | AKDAWEISRSSITLE CCCHHHHCCCCCCCH | 18.00 | 27251275 | |
261 | Phosphorylation | DAWEISRSSITLERR CHHHHCCCCCCCHHH | 21.21 | 30108239 | |
262 | Phosphorylation | AWEISRSSITLERRL HHHHCCCCCCCHHHC | 20.62 | 23911959 | |
292 | Phosphorylation | STKVAVKTLKPGTMS CEEEEEEECCCCCCC | 33.15 | - | |
301 | Ubiquitination | KPGTMSPKAFLEEAQ CCCCCCHHHHHHHHH | 44.45 | - | |
341 | Phosphorylation | TEFMCHGSLLDFLKN EEEEECHHHHHHHHC | 11.33 | 27251275 | |
412 | Phosphorylation | RLIKDDEYNPCQGSK HHCCCCCCCCCCCCC | 31.25 | 27155012 | |
418 | Phosphorylation | EYNPCQGSKFPIKWT CCCCCCCCCCCCEEC | 12.78 | 30108239 | |
453 | Phosphorylation | ILLTELITKGRIPYP HHHHHHHHCCCCCCC | 39.82 | - | |
459 | Phosphorylation | ITKGRIPYPGMNKRE HHCCCCCCCCCCHHH | 15.28 | 20860994 | |
523 | Phosphorylation | FTSAEPQYQPGDQT- HHCCCCCCCCCCCC- | 27.65 | 7515063 | |
529 | Phosphorylation | QYQPGDQT------- CCCCCCCC------- | 45.37 | 23532336 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
412 | Y | Phosphorylation | Kinase | FGR | P09769 | PhosphoELM |
523 | Y | Phosphorylation | Kinase | CSK | P41240 | PhosphoELM |
523 | Y | Phosphorylation | Kinase | SRC | P12931 | Uniprot |
- | K | Ubiquitination | E3 ubiquitin ligase | SMURF1 | Q9HCE7 | PMID:20804422 |
- | K | Ubiquitination | E3 ubiquitin ligase | CBL | P22681 | PMID:12435267 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FGR_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FGR_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
WASP_HUMAN | WAS | physical | 8805332 | |
CBL_HUMAN | CBL | physical | 12435267 | |
WASP_HUMAN | WAS | physical | 8824280 | |
TNFL6_HUMAN | FASLG | physical | 17164290 | |
SH3K1_HUMAN | SH3KBP1 | physical | 15707590 | |
KHDR1_HUMAN | KHDRBS1 | physical | 15190072 | |
HS90A_HUMAN | HSP90AA1 | physical | 22939624 | |
STAT3_HUMAN | STAT3 | physical | 21988832 | |
NR1I2_HUMAN | NR1I2 | physical | 21988832 | |
NEMO_HUMAN | IKBKG | physical | 23131831 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-27; TYR-34; TYR-412;TYR-523 AND THR-529, AND MASS SPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-28; TYR-34; TYR-208 ANDTYR-412, AND MASS SPECTROMETRY. |